Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older

Inclusion Criteria: * Subjects 65 years or older generally in good health as determined by medical history, physical assessment and clinical judgment of the investigator. Exclusion Criteria: * Subjects who have received influenza vaccine within the past 6 month and who have received adjuvanted vaccine in the past two years. * Subjects with hypersensitivity to vaccine components. Subjects who are on or were recently on immunosuppressive therapy.